Research Studies
Back to Results
Assessing the Transcriptional Response in Nasal Epithelium to the Triple CFTR modulator (ARNET)
Details
Age
Child
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Observational
Location
Childrens Hospital Colorado
Principal Investigator
Scott Sagel
Study ID
Protocol Number: 20-2738
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers